// App-Quantinova.ai

11573 : Targeting embryonic transcription factors to affect cancer stem cells and systemic therapy.

Researchers

Presenter

  • John Milburn Jessup

Principal Investigators

  • Robert J. Kinders

  • Scott M Lawrence

  • Abid R Mattoo

Medical Centers

  • Inova Schar Cancer Institute, Fairfax, VA

  • Leidos-Frederick, Frederick, MD

  • Leidos-Frederick, Frederick, MD

  • The Methodist Hospital Research Institute, Houston, TX

Locations

  • United States

Companies

  • Leidos Biomedical Re

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • NANOG

Drug/Treatment

  • Topotecan Hydrochloride

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final